|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Original Articles |
Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia
VII. Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy
1 Kresge Eye Institute, Wayne State University, Detroit, Michigan, and the
2 Department of Medicine, Case Western Reserve University, Cleveland, Ohio
Antioxidants were administered to diabetic rats and experimentally galactosemic rats to evaluate the ability of these agents to inhibit the development of diabetic retinopathy. Alloxan diabetic rats and nondiabetic rats that were fed 30% galactose randomly received standard diets or the diets supplemented with ascorbic acid and 
-tocopherol (vitamins C+E diet) or a more comprehensive mixture of antioxidants (multi-antioxidant diet), including Trolox, -tocopherol, N-acetyl cysteine, ascorbic acid, ß-carotene, and selenium. Diabetes or galactose feeding of at least 12 months resulted in pericyte loss, acellular capillaries, and basement membrane thickening. Compared with diabetic controls, the development of acellular capillaries was inhibited by 50% (P < 0.05) in diabetic rats that received supplemental vitamins C+E, and the number of pericyte ghosts tended to be reduced. The vitamins C+E supplement had no beneficial effect in galactosemic rats, but these rats consumed only approximately half as much of the antioxidants as the diabetic rats. The multi-antioxidant diet significantly inhibited (
55–65%) formation of both pericyte ghosts and acellular capillaries in diabetic rats and galactosemic rats (P < 0.05 vs. controls), without affecting the severity of hyperglycemia. Parameters of retinal oxidative stress, protein kinase C activity, and nitric oxides remained elevated for at least 1 year of hyperglycemia, and these abnormalities were normalized by multi-antioxidant therapy. Thus, long-term administration of antioxidants can inhibit the development of the early stages of diabetic retinopathy, and the mechanism by which this action occurs warrants further investigation. Supplementation with antioxidants can offer an achievable and inexpensive adjunct therapy to help inhibit the development of retinopathy in diabetes.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  R. A. Kowluru, M. Kanwar, P.-S. Chan, and J. P. Zhang Inhibition of Retinopathy and Retinal Metabolic Abnormalities in Diabetic Rats With AREDS-Based Micronutrients Arch Ophthalmol, September 1, 2008; 126(9): 1266 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Field, V. M. Elner, D. G. Puro, J. M. Feuerman, D. C. Musch, R. Pop-Busui, R. Hackel, J. R. Heckenlively, and H. R. Petty Rapid, Noninvasive Detection of Diabetes-Induced Retinal Metabolic Stress Arch Ophthalmol, July 1, 2008; 126(7): 934 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Leal, A. Manivannan, K.-I. Hosoya, T. Terasaki, J. Cunha-Vaz, A. F. Ambrosio, and J. V. Forrester Inducible Nitric Oxide Synthase Isoform Is a Key Mediator of Leukostasis and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5257 - 5265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chen, A. M. Guo, P. A. Edwards, G. Trick, and A. G. Scicli Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1619 - R1629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kanwar, P.-S. Chan, T. S. Kern, and R. A. Kowluru Oxidative Damage in the Retinal Mitochondria of Diabetic Mice: Possible Protection by Superoxide Dismutase Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3805 - 3811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Shelton, T. S. Kern, and J. J. Mieyal Glutaredoxin Regulates Nuclear Factor {kappa}-B and Intercellular Adhesion Molecule in Muller Cells: MODEL OF DIABETIC RETINOPATHY J. Biol. Chem., April 27, 2007; 282(17): 12467 - 12474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Kern, C. M. Miller, Y. Du, L. Zheng, S. Mohr, S. L. Ball, M. Kim, J. A. Jamison, and D. P. Bingaman Topical Administration of Nepafenac Inhibits Diabetes-Induced Retinal Microvascular Disease and Underlying Abnormalities of Retinal Metabolism and Physiology Diabetes, February 1, 2007; 56(2): 373 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zheng, B. Gong, D. A. Hatala, and T. S. Kern Retinal Ischemia and Reperfusion Causes Capillary Degeneration: Similarities to Diabetes Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 361 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Forges, P. Monnier-Barbarino, B. Leheup, and P. Jouvet Pathophysiology of impaired ovarian function in galactosaemia Hum. Reprod. Update, September 1, 2006; 12(5): 573 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Ola, D. A. Berkich, Y. Xu, M. T. King, T. W. Gardner, I. Simpson, and K. F. LaNoue Analysis of glucose metabolism in diabetic rat retinas Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1057 - E1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kowluru, L. Atasi, and Y.-S. Ho Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1594 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Luan, R. Roberts, M. Sniegowski, D. J. Goebel, and B. A. Berkowitz Retinal Thickness and Subnormal Retinal Oxygenation Response in Experimental Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 320 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S.F. Doney, S. Lee, G. P. Leese, A. D. Morris, and C. N.A. Palmer Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With the Glutathione S Transferase Theta-Null Genotype: A Go-DARTS Study Circulation, June 7, 2005; 111(22): 2927 - 2934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Barber, D. A. Antonetti, T. S. Kern, C. E. N. Reiter, R. S. Soans, J. K. Krady, S. W. Levison, T. W. Gardner, and S. K. Bronson The Ins2Akita Mouse as a Model of Early Retinal Complications in Diabetes Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2210 - 2218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fernandez-Robredo, D. Moya, J. A. Rodriguez, and A. Garcia-Layana Vitamins C and E Reduce Retinal Oxidative Stress and Nitric Oxide Metabolites and Prevent Ultrastructural Alterations in Porcine Hypercholesterolemia Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1140 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Mustata, M. Rosca, K. M. Biemel, O. Reihl, M. A. Smith, A. Viswanathan, C. Strauch, Y. Du, J. Tang, T. S. Kern, et al. Paradoxical Effects of Green Tea (Camellia Sinensis) and Antioxidant Vitamins in Diabetic Rats: Improved Retinopathy and Renal Mitochondrial Defects but Deterioration of Collagen Matrix Glycoxidation and Cross-Linking Diabetes, February 1, 2005; 54(2): 517 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kowluru and S. Odenbach Effect of Long-Term Administration of {alpha}-Lipoic Acid on Retinal Capillary Cell Death and the Development of Retinopathy in Diabetic Rats Diabetes, December 1, 2004; 53(12): 3233 - 3238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kowluru and S. Odenbach Role of Interleukin-1{beta} in the Development of Retinopathy in Rats: Effect of Antioxidants Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4161 - 4166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R A Kowluru and S Odenbach Role of interleukin-1{beta} in the pathogenesis of diabetic retinopathy Br. J. Ophthalmol., October 1, 2004; 88(10): 1343 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Dagher, Y. S. Park, V. Asnaghi, T. Hoehn, C. Gerhardinger, and M. Lorenzi Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy Diabetes, September 1, 2004; 53(9): 2404 - 2411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Hosoya, A. Minamizono, K. Katayama, T. Terasaki, and M. Tomi Vitamin C Transport in Oxidized Form across the Rat Blood-Retinal Barrier Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1232 - 1239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kowluru, A. Kowluru, S. Chakrabarti, and Z. Khan Potential Contributory Role of H-Ras, a Small G-Protein, in the Development of Retinopathy in Diabetic Rats Diabetes, March 1, 2004; 53(3): 775 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Frank Diabetic Retinopathy N. Engl. J. Med., January 1, 2004; 350(1): 48 - 58. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kowluru and S. N. Abbas Diabetes-Induced Mitochondrial Dysfunction in the Retina Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5327 - 5334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. El-Remessy, G. Abou-Mohamed, R. W. Caldwell, and R. B. Caldwell High Glucose-Induced Tyrosine Nitration in Endothelial Cells: Role of eNOS Uncoupling and Aldose Reductase Activation Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3135 - 3143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kowluru Effect of Reinstitution of Good Glycemic Control on Retinal Oxidative Stress and Nitrative Stress in Diabetic Rats Diabetes, March 1, 2003; 52(3): 818 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. G. Obrosova, A. G. Minchenko, R. Vasupuram, L. White, O. I. Abatan, A. K. Kumagai, R. N. Frank, and M. J. Stevens Aldose Reductase Inhibitor Fidarestat Prevents Retinal Oxidative Stress and Vascular Endothelial Growth Factor Overexpression in Streptozotocin-Diabetic Rats Diabetes, March 1, 2003; 52(3): 864 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. He, C. Rask-Madsen, and G.L. King Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. Sheetz and G. L. King Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA, November 27, 2002; 288(20): 2579 - 2588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kowluru and P. Koppolu Termination of Experimental Galactosemia in Rats, and Progression of Retinal Metabolic Abnormalities Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3287 - 3291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stitt, T. A. Gardiner, N. L. Anderson, P. Canning, N. Frizzell, N. Duffy, C. Boyle, A. S. Januszewski, M. Chachich, J. W. Baynes, et al. The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes Diabetes, September 1, 2002; 51(9): 2826 - 2832. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |